Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analy...

por Flamm, Jason A, Vanig, Thanes, Gathe, Joseph, Kinder, Clifford, Para, Michael, Rashbaum, Bruce, Segal-Maurer, Sorana, Shamblaw, David, Wohlfeiler, Michael, Young, Benjamin, Zurawski, Christine, Rhee, Martin S
Publicado 2017

Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care

por Davy-Mendez, Thibaut, Sarovar, Varada, Levine-Hall, Tory, Lea, Alexandra N., Leibowitz, Amy S., Luu, Mitchell N., Flamm, Jason A., Hare, C. Bradley, Dumoit Smith, Jaime, Iturralde, Esti, Dilley, James, Silverberg, Michael J., Satre, Derek D.
Publicado 2023

Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (...

por Czarnogorski, Maggie, Garris, Cindy P., Dalessandro, Marybeth, D'Amico, Ronald, Nwafor, Toyin, Williams, Will, Merrill, Deanna, Wang, YuanYuan, Stassek, Larissa, Wohlfeiler, Michael B., Sinclair, Gary I., Mena, Leandro A., Thedinger, Blair, Flamm, Jason A., Benson, Paul, Spreen, William R.
Publicado 2022

Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementat...

por Garris, Cindy P., Czarnogorski, Maggie, Dalessandro, Marybeth, D'Amico, Ronald, Nwafor, Toyin, Williams, Will, Merrill, Deanna, Wang, YuanYuan, Stassek, Larissa, Wohlfeiler, Michael B., Sinclair, Gary I., Mena, Leandro A., Thedinger, Blair, Flamm, Jason A., Benson, Paul, Spreen, William R.
Publicado 2022